Show simple item record

dc.contributor.authorVillarreal-Zegarra, D.
dc.contributor.authorCarrillo-Larco, R.M.
dc.contributor.authorBernabe-Ortiz, A.
dc.date.accessioned2025-10-31T18:35:49Z
dc.date.available2025-10-31T18:35:49Z
dc.date.issued2021
dc.identifier.urihttps://hdl.handle.net/20.500.12805/5333
dc.description.abstractThe prevalence of hypertension has been declining in low- and middle-income countries (LMIC), particularly in Latin America and the Caribbean. However, we have not identified studies that evaluate trends for awareness, treatment, and control of hypertension in LMIC. We aimed to describe the trends in the prevalence, awareness, treatment, and control of hypertension in Peru. A cross-sectional analysis was conducted using secondary data (4 years) of the Demographic and Health Survey of Peru (ENDES, Spanish acronym), which is conducted annually and is representative at the country level. The age-standardized prevalence was estimated using the World Health Organization population as the reference population. The trend over time was evaluated with the score test for trend of odds. A total of 109,401 participants were included. In Peru, from 2015 to 2018, the age-standardized prevalence of hypertension increased (p < 0.001), while the proportion of people with disease awareness (p < 0.001) and controlled hypertension decreased (p = 0.01). During that same period, the proportion of people with treatment for hypertension did not vary over time (p = 0.13). In 2018, the age-standardized prevalence of hypertension was 20.6%, and the proportion of people with disease awareness, treatment, and control of arterial hypertension was 43.5%, 20.6%, 5.3%, respectively. People with low socioeconomic status and people living in rural areas have the lowest proportion of awareness, treatment, and control of hypertension.en_US
dc.description.sponsorshipFunding This work was supported by the Strategic Award, Wellcome Trust-Imperial College Centre for Global Health Research (100693/Z/ 12/Z), Imperial College London Wellcome Trust Institutional Strategic Support Fund [Global Health Clinical Research Training Fellowship] (294834/Z/16/Z ISSF ICL), and RMC-L are supported by a Wellcome Trust International Training Fellowship (214185/Z/18/Z). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.
dc.formatapplication/pdf
dc.language.isoeng
dc.publisherSpringer Nature
dc.relation.ispartofurn:issn:1476-5527
dc.rightshttps://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectHypertension Management and Dietary Sodium Impacten_US
dc.subjectHypertension Control and Public Health Impacten_US
dc.titleShort-term trends in the prevalence, awareness, treatment, and control of arterial hypertension in Peruen_US
dc.typehttps://purl.org/coar/resource_type/c_2df8fbb1
dc.identifier.doihttps://doi.org/10.1038/s41371-020-0361-1
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.03.00
dc.type.otherResearch article
dc.identifier.journalJournal of Human Hypertension
dc.type.versionhttps://purl.org/coar/version/c_970fb48d4fbd8a85


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2